Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
Insiders Menu
Roster
Transactions
Rubius Therapeutics, Inc. (RUBY)
Date
Name
Title
Type
Security
Shares
Price
Value
Ownership
Reported
02/24/2023
Appelhans Dannielle
CEO and President
Sale
Common Stock
10.4k
$0.13
$1.3k
02/24/2023
02/01/2023
Appelhans Dannielle
CEO and President
Sale
Common Stock
3.9k
$0.25
$969.5
01/31/2023
02/01/2023
CAGNONI PABLO J
Director
Sale
Common Stock
8.4k
$0.25
$2.1k
02/01/2023
01/31/2023
Appelhans Dannielle
CEO and President
Exercise
Restricted Stock Units
7.5k
$0.00
$0
01/31/2023
08/10/2022
Appelhans Dannielle
CEO and President
Sale
Common Stock
5.7k
$0.80
$4.6k
08/09/2022
08/09/2022
Appelhans Dannielle
CEO and President
Exercise
Restricted Stock Units
12.5k
$0.00
$0
08/09/2022
07/29/2022
Schaffert Susanne
Director
Grant
Stock Option (Right to Buy)
50k
$0.70
$35.1k
07/29/2022
05/12/2022
Prener Anne
Director
Grant
Stock Option (Right to Buy)
25k
$1.24
$31k
05/12/2022
05/12/2022
Rosenblatt Michael
Director
Grant
Stock Option (Right to Buy)
25k
$1.24
$31k
05/12/2022
05/12/2022
Cuss Francis M
Director
Grant
Stock Option (Right to Buy)
25k
$1.24
$31k
05/12/2022
05/12/2022
Sohn Catherine A.
Director
Grant
Stock Option (Right to Buy)
25k
$1.24
$31k
05/12/2022
05/12/2022
Epstein David R
Director
Grant
Stock Option (Right to Buy)
499.8k
$1.24
$619.7k
05/12/2022
04/21/2022
Epstein David R
Director
Purchase
Common Stock
30k
$1.44
$43.3k
04/21/2022
02/01/2022
CAGNONI PABLO J
Director
Sale
Common Stock
6.7k
$6.57
$44.2k
01/29/2022
02/01/2022
Keson-Brookes Maiken
CLO & Corp. Secretary
Sale
Common Stock
2.7k
$6.57
$18k
01/29/2022
02/01/2022
Turka Laurence A.
Chief Scientific Officer
Sale
Common Stock
2.5k
$6.57
$16.5k
01/29/2022
01/31/2022
Turka Laurence A.
Chief Scientific Officer
Grant
Stock Option (Right to Buy)
143.8k
$6.75
$970.3k
01/29/2022
01/31/2022
Turka Laurence A.
Chief Scientific Officer
Grant
Restricted Stock Units
34.5k
$0.00
$0
01/29/2022
01/31/2022
Appelhans Dannielle
CEO and President
Grant
Stock Option (Right to Buy)
125k
$6.75
$843.8k
01/31/2022
01/31/2022
Appelhans Dannielle
CEO and President
Grant
Restricted Stock Units
30k
$0.00
$0
01/31/2022
01/31/2022
Keson-Brookes Maiken
CLO & Corp. Secretary
Grant
Stock Option (Right to Buy)
143.8k
$6.75
$970.3k
01/29/2022
01/31/2022
Keson-Brookes Maiken
CLO & Corp. Secretary
Grant
Restricted Stock Units
34.5k
$0.00
$0
01/29/2022
01/31/2022
Carmona Jose
CFO
Grant
Stock Option (Right to Buy)
143.8k
$6.75
$970.3k
01/31/2022
01/31/2022
Carmona Jose
CFO
Grant
Restricted Stock Units
34.5k
$0.00
$0
01/31/2022
01/31/2022
CAGNONI PABLO J
Director
Grant
Stock Option (Right to Buy)
365k
$6.75
$2.5M
01/29/2022
01/31/2022
CAGNONI PABLO J
Director
Grant
Restricted Stock Units
100k
$0.00
$0
01/29/2022
01/29/2022
CAGNONI PABLO J
Director
Exercise
Restricted Stock Units
21.2k
$0.00
$0
01/29/2022
01/29/2022
Keson-Brookes Maiken
CLO & Corp. Secretary
Exercise
Restricted Stock Units
8.1k
$0.00
$0
01/29/2022
01/29/2022
Turka Laurence A.
Chief Scientific Officer
Exercise
Restricted Stock Units
7.4k
$0.00
$0
01/29/2022
08/31/2021
Appelhans Dannielle
CEO and President
Grant
Restricted Stock Units
50k
$0.00
$0
08/31/2021
08/31/2021
Appelhans Dannielle
CEO and President
Grant
Stock Option (Right to Buy)
150k
$21.72
$3.3M
08/31/2021
03/19/2021
Flagship Ventures Fund IV General Partner LLC
10% Owner
Purchase
Common Stock
70k
$29.00
$2M
See Footnote
03/19/2021
03/19/2021
Flagship Ventures Fund IV General Partner LLC
10% Owner
Purchase
Common Stock
70k
$29.00
$2M
See Footnote
03/19/2021
03/19/2021
Flagship Ventures Fund IV General Partner LLC
10% Owner
Purchase
Common Stock
70k
$29.00
$2M
See Footnote
03/19/2021
02/11/2021
Epstein David R
Director
Sale
Common Stock
26.7k
$14.93
$398.6k
02/11/2021
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy